Trial intelligence / Profile preview

RECONSTRUCT study

2016-003509-33Phase 4Completed

Sponsor
Copenhagen University Hospital Hvidovre, Department of Respiratory Medicine
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of Budicort in asthma (3 arms), sponsored by Copenhagen University Hospital Hvidovre, Department of Respiratory Medicine. Primary endpoint: Change in airway hyperresponsiveness per change in Na+, K+ pump content. Started Sep 2016; status: completed.

02

Drugs

Budicort
03

Conditions

asthma

Beyond the preview

Go deeper on 2016-003509-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003509-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call